Talos Energy Inc. (NYSE:TALO) recent drop took place on significantly more volume which surged nearly 263651 contracts on 23-May-19 versus its daily average of 216340. The first sale was made at $27.81 but later the stock became weaker, and closed with a fall of -7.79%. It was last traded at $24.73 apiece.

Talos Energy Inc. (TALO): Buy Candidate With 63.77% Upside Potential

Talos Energy Inc. is maintained at an average buy rating by 6 stock analysts, and there are at least 2.74% of shares outstanding that are currently legally short sold. The shares went down by -15.8% in value last month. Year-to-date it jumped 51.53%. Analysts are turning out to be more optimistic than before, with 6 of analysts who cover Talos Energy Inc. (NYSE:TALO) advice adding it to buy candidate list. Wall Street experts also assign a $40.5 price target on Talos Energy Inc., pointing towards a 63.77% rally from current levels. The stock is trading for about -34.3% less than its 52-week high.

Talos Energy Inc. Reports -33.29% Sales Growth

Talos Energy Inc. (TALO) remained successful in beating the consensus-estimated $0.76 as it actually earned $0.82 per share in its last reported financial results. Revenue, on the other hand, scored -33.29% growth from the previous quarter, coming up with $172.56 million.

TALO Retreats -12.8% In A Week

This company shares (TALO) so far managed to recover 69.38% since collapsing to its 52-week low. Over a week, it has seen its stock price volatility to stay at 4.17% while widening the period to a month, volatility was 4.01%. The share price has yet to cross its 20 days moving average, floating at a distance of -13.33% and sits -10.08% lower versus its 50 days moving average. When looking at the past five sessions, the stock returned -12.8% losses and is down by -3.9% compared with its 200-day moving average of $22.85. Also, Talos Energy Inc. (TALO) needs to overturn a -26% decrease it experienced over the past twelve months.

Obalon Therapeutics, Inc. (NASDAQ:OBLN) Consensus Call At 2.2

As regular trading ended, Obalon Therapeutics, Inc. (OBLN) stock brought in a -$0.62 drop to $0.68. The day started at a price of $0.931 but then traded as high as $1.64 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2.2. Obalon Therapeutics, Inc. is given 2 buy-equivalent recommendations, 0 sells and 3 holds. The company shares sank -81.62% from their peak of $3.7 and now has a $16.64 million market value of equity.

Obalon Therapeutics, Inc. Could Grow 169.12% More

OBLN’s mean recommendation on Reuter’s scale presents no change from 2.17 thirty days ago to 2.17 now, which indicates a hold consensus from the analyst community. They see Obalon Therapeutics, Inc. (OBLN) price hitting a mean target of $1.83 a share, meaning the stock still has potential that could lift the price another 169.12% . Also, the recent close suggests the stock is underpriced by 341.18% compared to the most bullish target.

Obalon Therapeutics, Inc. (OBLN) Returns -67.15% This Year

The company had seen its current volume reaching at 24763422 shares in the last trade. That compares with the recent volume average of 19961820. At the close of regular trading, its last week’s stock price volatility was 18.9% which for the month reaches 35.97%. Obalon Therapeutics, Inc. dipped to as low as $0.81 throughout the day and has returned -67.15% in this year. At one point in the past year, the shares traded as low as $0.37 but has recovered 83.78% since then. [T4]